Key facts
- Notable investors include An Van Es-Johansson, Ben Peters, Heartfelt (Private Equity), Maarten Alblas, Stan Boland — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Cori Clinical
- ·The full record, as it builds
Funding rounds
No funding rounds for Cori Clinical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Cori Clinical
Developer of an artificial intelligence-powered digital assistant platform designed to support regulatory and operational workflows in clinical research. The company's platform manages clinical trial documentation, automates workflow steps from planning to launch, integrates with existing systems, and provides real-time tracking of milestones and actions, enabling healthcare teams to reduce manual effort and improve trial execution efficiency.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2024
- Employees
- 10
- Website
- cori-clinical.com/
- Ownership
- Privately Held (backing)
Cori Clinical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cori Clinical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cori Clinical in its N-PORT filings yet. We sweep new filings monthly.